Mostrando 10 resultados de: 22
Publisher
The Lancet Infectious Diseases(4)
BMC Nephrology(2)
Nature Communications(2)
Allergologia et Immunopathologia(1)
BMC Medicine(1)
Área temáticas
Medicina y salud(11)
Enfermedades(9)
Problemas sociales y servicios a grupos(8)
Medicina forense; incidencia de enfermedades(7)
Farmacología y terapéutica(4)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(20)
ODS 17: Alianzas para lograr los objetivos(17)
ODS 10: Reducción de las desigualdades(13)
ODS 6: Agua limpia y saneamiento(3)
ODS 12: Producción y consumo responsables(2)
Origen
scopus(22)
Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic
ArticleAbstract: BACKGROUND: Most studies assessing pathophysiological heterogeneity in asthma have been conducted inPalabras claves:adolescents, Asthma, CHILDREN, HIC, inflammatory phenotypes, LMIC, sputum inductionAutores:Ali H., Brooks C., Cruz A.A., Douwes J., Figueiredo C.A.V., Henderson J., Martha E. Chico, Mauricio L. Barreto, Mpairwe H., Nambuya I., Oviedo A.Y., Pearce N., Pembrey L., Philip John Cooper, Ring S., Robertson S., Rutter C.E., Tumwesige P., van Veldhoven K.Fuentes:scopusCoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study
ArticleAbstract: Background: More doses of CoronaVac have been administered worldwide than any other COVID-19 vaccinePalabras claves:covid-19, Inactivated vaccine, pregnant women, SARS-COV-2, Vaccine effectivenessAutores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Pinto Júnior E.P., Rodrigues L.C., Werneck G.L., Wong K.L.M.Fuentes:scopusDecline in kidney function among apparently healthy young adults at risk of Mesoamerican nephropathy
ArticleAbstract: Background Epidemic levels of CKD of undetermined cause, termed Mesoamerican nephropathy in CentralPalabras claves:Autores:Aragón A., Camacho A., Caplin B., Faber D., Glaser J., Hill M., La Rosa Garcia B., Le Blond J., Marvin Antonio González-Quiroz, Nitsch D., Oomatia A., Pearce N., Silverwood R.J., Smeeth L., Smpokou E.T., Wesseling C.Fuentes:scopusDuration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusEffectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil
OtherAbstract:Palabras claves:Autores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Rodrigues L.C., Werneck G.L.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusEffectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study
ArticleAbstract: Background AU Brazil: and Scotland have used mRNA boosters in their respective : populations since SPalabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Rudan I., Sanchez M., Shah S.A., Sheikh A., Werneck G.L.Fuentes:scopusGlobal Asthma Network survey suggests more national asthma strategies could reduce burden of asthma
ArticleAbstract: Background Several countries or regions within countries have an effective national asthma strategyPalabras claves:Asthma, burden, global, management, National, network, STRATEGIESAutores:Addo-Yobo E.O., Aguirre de Abruzzese J., Akpinar-Elci M., Annesi-Maesano I., Asher I., Awasthi S., Baghdasaryan A., Banac S., Barba S., Benhabylès B., Berihu A., Billo N.E., Birba E., Bissell K., Boukari R., Brandão H.V., Burgess S., Calvo Gil M.A., Camargos P.A.M., Castracane F.A., Charpin D., Chen Y.Z., Cheraghi M., Chiang C.Y., Clement N.F., de Britto M., Domuz S., El Falaki M., El Sony A., Ellwood E., Ellwood P., Figueroa Colorado M., Fischer G.B., Garcia E., Gninafon M., Gómez M., Gotua M., Gratziou C., Haahtela T., Haidinger G., Ilangho R., Kabengele Obel B., Kan X., Karimi M., Kartasasmita C.B., Kuschnir F.C., Lai C.K.W., Lal V.A., Lin Y., Lochte L., Maitra A., Makela M.J., Mallol J., Manning P., Marcos L.G., Marks G.B., Masjedi M.R., Mattes J., Mbatchou Ngahane B.H., Menezes A.M., Mokhtar A., Mukherjee M., Mustakov T.B., Niederbacher J., Novák Z., Ordoñez G.A., Pai U.A., Pearce N., Pefura Yone E.W., Pherwani A.V., Philip John Cooper, Porto Neto A.C., Priftanji A., Raherison C., Reddy B.K., Rennie D.C., Riedler J., Rosário N., Sabir M., Salmun N., Selroos O., Sharma S.K., Shohat T., Shpakou A., Singh M., Singh V., Solé D., Soto-Quiros M.E., Standring P., Strachan D., Sukumaran T.U., Tai A., To T., Tsanakas J., Varkki S., Von Mutius E., Wandalsen N.F., Weihe P., Weyler J., Yiallouros P.Fuentes:scopusGlobal prevention and control of NCDs: Limitations of the standard approach
ArticleAbstract: The five-target '25 × 25' strategy for tackling the emerging global epidemic of non-communicable disPalabras claves:Mortality , non-communicable diseases (NCDs), risk factors for NCDSAutores:Chimeddamba O., Ebrahim S., Foliaki S., Haines A., Lamptey P., Marcos L.G., Matheson D., Mauricio L. Barreto, Mckee M., Miranda J.J., Pearce N., Vineis P., Walls H.Fuentes:scopusHow well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two
ArticleAbstract: SummaryBackground Questionnaires are widely used in epidemiological studies to measure eczema symptoPalabras claves:Atopic dermatitis, atopic eczema, Diagnostic criteria, epidemiologyAutores:Aarts F.J.H., Abramidze T., Addo-Yobo E.O., Agolli S., Andrea Pinãna López, Annesi-Maesano I., Annus T., Arthur P., Augusto Maldonado, Bagrade L., Barry D., Björkstén B., Bolle R., BrAbäck L., Brunekreef B., Büchele G., Casno G., Chen Y.Z., Clausen M., Cooper P., Corbo G., Crane J., de Meer G., De Sario M., Doekes G., Dolidze N., Domenicantonio R.D., Flohr C., Forastiere F., Genuneit J., Gimeno A.M., Gotua M., Grabocka E., Gratziou C., Gurakuqi A., Hatziagorou E., Jansen-Van Vliet P.H.N., Janssen N.A.H., Jones M.H., Karsanidze L., Katsardis C., Keil U., Khubchandani R.P., Kiladze M., Kirvassilis F., Kleiner A., Kvachadze I., Lai C.K.W., Leupold W., Mantri S., Martha E. Chico, Mathur R.S., Nagel G., Novikova I., Nystad W., Papadopoulou A., Pearce N., Perucci C.A., Philip John Cooper, Pistelli R., Pitrez P.M., Priftanji A., Priftis C., Riikjärv M.A., Rukhadze M., Sammarro S., Schram D., Sebre D., Serra M.G., Shah J.R., Sharif N.E., Shkurti A., Shyti K., Simenati J., Stein R.T., Suarez-Varela M.M.M., Svabe V., Tsanakas J., Urrutia De Pereira M., Von Mutius E., Von Mutius E.R.M., Weiland S.K., Weinmayr G., Wickens K., Williams H.C., Wong G., Wong G.W.K., Yu M., Zhong N.S.Fuentes:scopus